Skip to main content
. 2014 Nov 1;6(5):1178–1189. doi: 10.4161/mabs.32114

Figure 7.

Figure 7.

The human PK assay prototype was established by reformatting the nonclinical PK assay for use with human serum matrix. The standard curve comparison of the biosimilar, the FDA-licensed, and EU-authorized reference products in the human PK prototype assay are presented, with the profiles showing the 3 products were comparable within the method. Mean (n = 2), + SD plotted; CVs ≤ 3%. Recoveries for the standard curve points were within ± 14% of nominal.